A Bet on Red-Hot Cybersecurity

Nicholas Vardy

Nicholas Vardy has a unique background that has proven his knack for making money in different markets around the world.

Last week was mixed for U.S. stock markets, with the Dow Jones up 0.28%, the S&P 500 flattish — rising only 0.06% — and the NASDAQ down 0.34%. The MCSI Emerging Markets Index eked out a 0.32% gain.

Big gainers in your Bull Market Alert portfolio included Silicon Motion Technology (SIMO), which gained 1.94%, and Halyard Health Inc. (HYH), which added 1.66%.

You hit your tightened stops on both Regeneron (REGN) and Ambarella Inc. (AMBA). You booked a 10% gain in Regeneron. Your remaining REGN August $480 calls sold at $62.18 for a 63.63% gain. Total return on REGN options was a 71.29% gain.

You booked a huge 40.02% gain in your Ambarella (AMBA) stock, which moved up so quickly, I didn’t even have a chance to recommend options on the position.

Your position in the iShares MSCI Hong Kong (EWH) fell below its 50-day moving average and now is a HOLD.

With your Market Vectors Biotech ETF (BBH) June $132 call options (BBH150619C00132000) expiring this Friday, I am recommending that you cut your losses on this play.

This week’s Bull Market Alert recommendation — Qualys Inc. (QLYS) — takes you into the red-hot area of cybersecurity.

Silicon Valley-based Qualys provides cloud security that enables organizations to identify security risks to their IT infrastructure quickly.

Here’s why I expect the QLYS stock to continue upward in the coming months.

First, QLYS is in a hot sector. While the broader U.S. market is having trouble gaining traction in 2015, the cybersecurity space — as measured by the ISE Cyber Security Index — is up by more than 21% this year.

Exclusive  REIT ETFs Are Top Heavy in Tech

Second, QLYS is a company on the move. Last week, Qualys and ForeScout Technologies, which provides continuous monitoring, announced a partnership that will integrate their security appliances to give joint customers real-time assessment and mitigation capabilities.

Third, the recent pullback in the company’s stock price offers a terrific opportunity to enter the stock. On June 5, the company reported worse-than-expected quarterly results and the stock fell 33% for the day.

That sell-off was overdone. The proof? Insiders are buying the stock on any bout of weakness. A QLYS director recently bought 50,000 shares, or about $1.87 million worth of stock, at just over $37.00 per share.

I recommend you do the same. So buy Qualys (QLYS) at market today and place your stop at $34.00. Wunderlich Securities just initiated coverage of Qualys with a buy rating and a $50 price target. That’s almost 20% above Friday’s closing price.

If you want to play the options, I recommend the September $45.00 calls (QLYS150918C00045000), which last traded at $3.00 and expire Sept. 18.

Portfolio Update

Halyard Health Inc. (HYH) added 1.66%. This position continued to trade sideways for another week of consolidation. Remaining very oversold, HYH is still poised to move higher. Short interest in HYH also took a 7% drop recently, suggesting that the traders betting on lower prices are starting to throw in the towel. HYH is a HOLD.

ProShares Ultra Nasdaq Biotechnology ETF (BIB) dipped 1.73%. BIB remains at its elevated price levels as it traded sideways yet another week along the 3x-tested $90 resistance level. This also represents a point very close to its late March 52-week high near $95. BIB is above its 50-day moving average (MA) and remains a BUY.

Exclusive  Did You Sleep Through the Retail Recovery?

iShares MSCI Hong Kong (EWH) gave back 1.18%. EWH is a non-leveraged fund that gives you exposure to the Hong Kong market, thereby giving you indirect exposure to the movement of the closely linked Chinese market. Its major exposure falls under Financials with a 65% allocation. EWH also has 10-12% allocations to Industrials, Utilities and Consumer Discretionary holdings. EWH fell below the 50-day MA to become a HOLD.

WisdomTree Europe Hedged Equity Fund (HEDJ) closed the week flat. Although the relentless rise of the U.S. dollar has done wonders for the buying power of vacationing Americans during their European vacations, it’s had the opposite effect on some of their European investments. HEDJ hedges that risk. HEDJ is a HOLD.

Silicon Motion Technology (SIMO) gained 1.94%. In addition to the positive earnings catalysts I highlighted in my recent SIMO recommendation, this play on the high tech sector currently pays a 1.70% dividend on a quarterly basis. SIMO also enjoys a low, declining short interest in its shares outstanding as it recently marked a month-over-month dip from 1.42 million shares sold short to 1.38 million shares. SIMO is a BUY.

Latest Special Report

As a courtesy, I invite you to view my newly created special report, The Biotech Millionaire Map. This report and others are available FREE on my website to you.

NEW FEATURE — Receive your alerts via text! You now can receive a text message on your cell phone to inform you whenever a trading alert is sent. To add this free new benefit to your service, please send an email to CustomerService@NicholasVardy.com with the following information and mention in the email that you want your cell phone added to your account:

  • Your Name
  • Your Zip Code
  • Your Email Address
  • Your Cell Phone number
Exclusive  The Economy is Doing Better Than We Thought

Please note that we can only deliver text messages to cell phones with U.S. or Canadian numbers. Standard text messaging rates from your provider apply.

Nicholas Vardy

Like This Article?
Now Get Our FREE Special Report:
Alternative Investing: Investing in Timber

Stock Investor editor Paul Dykewicz reveals why investing in timber may be one of the best long-term portfolio strategies you'll find today.

Get Access to the Report, 100% FREE

previous article

Hear Eagle Daily Investor Editor Paul Dykewicz discuss the latest about the weak U.S. economy, the financial fallout in Baltimore since the April 27 riot and lessons for city leaders elsewhere about how to avoid civil unrest in their own communities.


Dr. Mark Skousen

Named one of the "Top 20 Living Economists," Dr. Skousen is a professional economist, investment expert, university professor, and author of more than 25 books.

Product Details


Bryan Perry

A former Wall Street financial advisor with three decades' experience, Bryan Perry focuses his efforts on high-yield income investing and quick-hitting options plays.

Product Details


Jim Woods

Jim Woods has over 20 years of experience in the markets from working as a stockbroker,
financial journalist, and money manager. As well as a book author and regular contributor to
numerous investment websites, Jim is the editor of:

Product Details


Bob Carlson

Bob Carlson provides independent, objective research covering all the financial issues of retirement and retirement planning. In addition, Bob serves as Chairman of the Board of Trustees of the Fairfax County (VA) Employees’ Retirement System, which has over $2.8 billion in assets.

Product Details


Hilary Kramer

Hilary Kramer is an investment analyst and portfolio manager with 30 years of experience on Wall Street. Since 2010, Hilary's financial publications have provided stock analysis and investment advice to her subscribers:

Product Details


Jon Johnson

Jon Johnson's philosophy in investing and trading is to take what the market gives you regardless if that is to the upside or downside. For the past 21 years, Jon has helped thousands of clients gain success in the financial markets through his newsletters and education services:

Product Details



Used by financial advisors and individual investors all over the world, DividendInvestor.com is the premier provider and one-stop shop for dividend information and research.

Product Details

Popular tools include our proprietary Dividend Calendar, Dividend Calculator, Dividend Score Card, and many more.